We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
Cap. Flow
+$1.82B
Cap. Flow %
5.13%
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$172M
2
HON icon
Honeywell
HON
+$160M
3
MSFT icon
Microsoft
MSFT
+$159M
4
AMZN icon
Amazon
AMZN
+$91M
5
TSLA icon
Tesla
TSLA
+$89.8M

Sector Composition

Rank Sector Weight
1 Technology 27.11%
2 Consumer Discretionary 14.43%
3 Communication Services 10.72%
4 Healthcare 9.96%
5 Financials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
1351
Madrigal Pharmaceuticals
MDGL
$12.6B
$399K ﹤0.01%
4,999
-927
-16% -$80.1K
ARCT icon
1352
Arcturus Therapeutics
ARCT
$157M
$398K ﹤0.01%
8,329
-1,879
-18% -$84.2K
URBN icon
1353
Urban Outfitters
URBN
$5.99B
$397K ﹤0.01%
13,364
-9,652
-42% -$345K
AN icon
1354
AutoNation
AN
$6.97B
$395K ﹤0.01%
3,248
-1,094
-25% -$124K
DORM icon
1355
Dorman Products
DORM
$4.01B
$395K ﹤0.01%
4,171
-3,545
-46% -$350K
HSKA
1356
DELISTED
Heska Corp
HSKA
$395K ﹤0.01%
1,528
-1,226
-45% -$313K
KTB icon
1357
Kontoor Brands
KTB
$4.62B
$394K ﹤0.01%
7,883
-6,859
-47% -$380K
FIX icon
1358
Comfort Systems
FIX
$61B
$393K ﹤0.01%
5,507
-4,729
-46% -$352K
YMAB
1359
DELISTED
Y-mAbs Therapeutics
YMAB
$393K ﹤0.01%
13,787
-3,107
-18% -$97.9K
NTCT icon
1360
NETSCOUT
NTCT
$2.86B
$392K ﹤0.01%
14,531
-9,648
-40% -$267K
IBP icon
1361
Installed Building Products
IBP
$6.13B
$391K ﹤0.01%
3,646
-3,123
-46% -$372K
EXAS
1362
DELISTED
Exact Sciences
EXAS
$389K ﹤0.01%
4,076
-2,127
-34% -$225K
IMGN
1363
DELISTED
Immunogen Inc
IMGN
$389K ﹤0.01%
68,587
-18,029
-21% -$104K
WBT
1364
DELISTED
Welbilt, Inc.
WBT
$389K ﹤0.01%
16,758
-17,164
-51% -$403K
CWEN icon
1365
Clearway Energy Class C
CWEN
$5B
$388K ﹤0.01%
12,803
-8,488
-40% -$253K
P
1366
Everpure Inc
P
$24.8B
$388K ﹤0.01%
15,436
+895
+6% +$19.8K
ORA icon
1367
Ormat Technologies
ORA
$6.11B
$387K ﹤0.01%
5,809
-5,951
-51% -$411K
PLXS icon
1368
Plexus
PLXS
$6.81B
$387K ﹤0.01%
4,323
-3,806
-47% -$338K
MARA icon
1369
Marathon Digital Holdings
MARA
$4.62B
$386K ﹤0.01%
12,221
-12,548
-51% -$408K
PHR icon
1370
Phreesia
PHR
$632M
$386K ﹤0.01%
6,264
-3,626
-37% -$242K
ERIE icon
1371
Erie Indemnity
ERIE
$11.7B
$385K ﹤0.01%
2,157
+25
+1% +$4.52K
OPLN
1372
Openlane
OPLN
$4.17B
$385K ﹤0.01%
23,510
-18,254
-44% -$308K
UNIT
1373
Uniti Group
UNIT
$2.63B
$384K ﹤0.01%
31,020
-25,860
-45% -$315K
AXSM icon
1374
Axsome Therapeutics
AXSM
$12.4B
$383K ﹤0.01%
11,608
-2,350
-17% -$91.6K
CLH icon
1375
Clean Harbors
CLH
$16.1B
$383K ﹤0.01%
3,684
-472
-11% -$46.4K

Similar funds

ProShare Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.

  • ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
  • ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
  • ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
  • ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
  • ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
  • ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
  • ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.

Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.